Case Report: Treatment for steroid-refractory immune-related myocarditis with tofacitinib

INTRODUCTION: Immune therapy has ushered in a new era of tumor treatment, at the expense of immune-related adverse events, including rare but fatal adverse cardiovascular events, such as myocarditis. Steroids remain the cornerstone of therapy for immune-related myocarditis, with no clear consensus o...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Qian, Zhang, Zhongwei, Zhu, Biao, Lin, Qionghua, Shen, Lihua, Li, Fangfang, Xia, Zhili, Zhao, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521497/
https://www.ncbi.nlm.nih.gov/pubmed/36189247
http://dx.doi.org/10.3389/fimmu.2022.944013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521497/
https://www.ncbi.nlm.nih.gov/pubmed/36189247
http://dx.doi.org/10.3389/fimmu.2022.944013

Ejemplares similares